*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter - as a primary diagnosis code | T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 5.29 | |
| Readmission Rate (%) | 21.95 | |
| Unplanned Readmission Rate (%) | 13.75 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 101,548 | |
| Total Hospitalizations with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 97 | |
| DRG Share of Total Hospitalizations | 0.31 | |
| % of Total ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter in DRG | 59.15 | |
| Avg LOS at DRG | 4.68 | |
| Avg LOS with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 4.41 | |
| Readmission Rate at DRG | 32.74 | |
| Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 22.11 | |
| Unplanned Readmission Rate at DRG | 13.79 | |
| Unplanned Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 16.84 | |
| Total Medicare payments at DRG | $922,969,291 | |
| Total Medicare payments with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $843,412 | |
| Total Medicare payment per Day at DRG | $1,941 | |
| Total Medicare payment per Day with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $1,971 | |
| Total Medicare payment per Hospitalization at DRG | $9,089 | |
| Total Medicare payment per Hospitalization with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $8,695 | |
| Total Medicare Charges at DRG | $4,727,523,206 | |
| Total Medicare Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $3,694,209 | |
| Avg Charges at DRG | $46,555 | |
| Avg Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $38,085 | |
| Mortality Rate at DRG | 2.95 | |
| Mortality Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | NA | |
| SNF Discharge Rate at DRG | 13.87 | |
| SNF Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 30.93 | |
| Home Discharge Rate at DRG | 43.04 | |
| Home Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 35.05 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 122,730 | ||||
| Total Hospitalizations with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 1,617 | ||||
| DRG Share of Total Hospitalizations | 0.37 | ||||
| % of Total ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter in DRG | 10.63 | ||||
| Avg LOS at DRG | 7.61 | ||||
| Avg LOS with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 3.75 | ||||
| Readmission Rate at DRG | 21.31 | ||||
| Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 19.88 | ||||
| Unplanned Readmission Rate at DRG | 14.13 | ||||
| Unplanned Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 11.83 | ||||
| Total Medicare payments at DRG | $1,397,885,220 | ||||
| Total Medicare payments with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $9,079,189 | ||||
| Total Medicare payment per Day at DRG | $1,497 | ||||
| Total Medicare payment per Day with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $1,498 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,390 | ||||
| Total Medicare payment per Hospitalization with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $5,615 | ||||
| Total Medicare Charges at DRG | $4,175,290,309 | ||||
| Total Medicare Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $48,820,578 | ||||
| Avg Charges at DRG | $34,020 | ||||
| Avg Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $30,192 | ||||
| Mortality Rate at DRG | 0.28 | ||||
| Mortality Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 21.64 | ||||
| SNF Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 32.03 | ||||
| Home Discharge Rate at DRG | 28.06 | ||||
| Home Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 31.6 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 43,799 | ||||
| Total Hospitalizations with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 522 | ||||
| DRG Share of Total Hospitalizations | 0.13 | ||||
| % of Total ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter in DRG | 3.43 | ||||
| Avg LOS at DRG | 5.74 | ||||
| Avg LOS with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 2.95 | ||||
| Readmission Rate at DRG | 14.93 | ||||
| Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 16.7 | ||||
| Unplanned Readmission Rate at DRG | 8.84 | ||||
| Unplanned Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 8.75 | ||||
| Total Medicare payments at DRG | $370,803,163 | ||||
| Total Medicare payments with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $2,129,003 | ||||
| Total Medicare payment per Day at DRG | $1,476 | ||||
| Total Medicare payment per Day with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $1,383 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,466 | ||||
| Total Medicare payment per Hospitalization with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $4,079 | ||||
| Total Medicare Charges at DRG | $1,198,628,374 | ||||
| Total Medicare Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $12,909,262 | ||||
| Avg Charges at DRG | $27,367 | ||||
| Avg Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $24,730 | ||||
| Mortality Rate at DRG | 0.2 | ||||
| Mortality Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 16.4 | ||||
| SNF Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 26.44 | ||||
| Home Discharge Rate at DRG | 42.3 | ||||
| Home Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 45.59 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 885: PSYCHOSES | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 58,218 | ||||
| Total Hospitalizations with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 285 | ||||
| DRG Share of Total Hospitalizations | 0.18 | ||||
| % of Total ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter in DRG | 1.87 | ||||
| Avg LOS at DRG | 7.4 | ||||
| Avg LOS with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 4.35 | ||||
| Readmission Rate at DRG | 26.4 | ||||
| Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 25.75 | ||||
| Unplanned Readmission Rate at DRG | 19.51 | ||||
| Unplanned Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 17.16 | ||||
| Total Medicare payments at DRG | $694,366,430 | ||||
| Total Medicare payments with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $2,106,683 | ||||
| Total Medicare payment per Day at DRG | $1,611 | ||||
| Total Medicare payment per Day with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $1,698 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,927 | ||||
| Total Medicare payment per Hospitalization with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $7,392 | ||||
| Total Medicare Charges at DRG | $2,299,290,199 | ||||
| Total Medicare Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $10,655,305 | ||||
| Avg Charges at DRG | $39,494 | ||||
| Avg Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $37,387 | ||||
| Mortality Rate at DRG | 2.37 | ||||
| Mortality Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 20.38 | ||||
| SNF Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 24.91 | ||||
| Home Discharge Rate at DRG | 26.95 | ||||
| Home Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 37.89 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 070: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 68,556 | ||||
| Total Hospitalizations with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 146 | ||||
| DRG Share of Total Hospitalizations | 0.21 | ||||
| % of Total ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter in DRG | 0.96 | ||||
| Avg LOS at DRG | 6.18 | ||||
| Avg LOS with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 4.81 | ||||
| Readmission Rate at DRG | 21.52 | ||||
| Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 17.61 | ||||
| Unplanned Readmission Rate at DRG | 13.8 | ||||
| Unplanned Readmission Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 12.68 | ||||
| Total Medicare payments at DRG | $620,356,059 | ||||
| Total Medicare payments with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $1,029,594 | ||||
| Total Medicare payment per Day at DRG | $1,465 | ||||
| Total Medicare payment per Day with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $1,467 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,049 | ||||
| Total Medicare payment per Hospitalization with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $7,052 | ||||
| Total Medicare Charges at DRG | $2,302,271,203 | ||||
| Total Medicare Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $4,677,201 | ||||
| Avg Charges at DRG | $33,582 | ||||
| Avg Charges with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | $32,036 | ||||
| Mortality Rate at DRG | 0.66 | ||||
| Mortality Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 30.1 | ||||
| SNF Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 31.51 | ||||
| Home Discharge Rate at DRG | 26.94 | ||||
| Home Discharge Rate with ICD T428X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | 33.56 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| RIVERSIDE METHODIST HOSPITAL | 3535 OLENTANGY RIVER RD | COLUMBUS | OH | 43214 | 51 |
| BARNES JEWISH HOSPITAL | 1 BARNES-JEWISH HOSPITAL PLZ | SAINT LOUIS | MO | 63110 | 50 |
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 50 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 17 |
| Dr. MORAD L EL-RAHEB | 1145 S UTICA AVE | TULSA | OK | 74104 | 11 |